Medical Device Contract Manufacturing Market

The medical device contract manufacturing market is expected to grow from USD 85.59 billion in 2026 to reach USD 135.47 billion by 2031, growing at a CAGR of 9.6% during the forecast period.

Demand for outsourced medical device manufacturing is increasing as device makers shift more design, assembly, and packaging work to specialized partners. A primary driver of this growth is the expanding medical devices market in developing countries, where increased access to healthcare raises production volumes. OEMs often prefer to delegate these tasks to established manufacturing networks.

To know about the assumptions considered for the study download the pdf brochure

Additionally, advancements in medical device technologies—such as robotic-assisted surgical systems and minimally invasive catheters—require intricate assembly, welding, and validated processes. Patient convenience is also a growing focus, driving demand for specialized contract manufacturers. Home-use and wearable devices demand compact designs and high-volume production capabilities.

Robotics and automation are transforming how contract manufacturers operate their production lines. For instance, Sanmina reports that it automates the production of millions of disposable and personal monitoring devices each year. Adopting Industry 4.0 practices, including interconnected equipment and data-driven production, gives OEMs better visibility into quality and delivery processes, strengthening the case for outsourcing to manufacturers that have invested in these technologies.

The leading companies in the medical device contract manufacturing market include Jabil, Flex Ltd., Integer Holdings, Plexus, and Sanmina, among others. These firms have adopted various growth strategies—both organic and inorganic—such as establishing new product introduction centers, enhancing engineering capabilities, investing in technology, and pursuing acquisitions and collaborations. These efforts aim to shorten the time it takes OEMs to move devices from prototype to commercial production.

• In March 2025, Flex Ltd. opened a new product introduction center near Boston, Massachusetts, to support healthcare customers in North America. This facility will assist clients throughout the entire process, from prototype development to preclinical builds, design verification, and production transfer.
• On January 7, 2025, Integer acquired nearly all the assets of Precision Coating, a privately held manufacturer known for its high-value surface coating technology platforms, which include fluoropolymer coatings, anodic coatings, ion treatment solutions, and laser processing. The acquisition was valued at USD 152 million.

Jabil Inc. offers a wide range of electronics design, production, and product management services for companies across various industries and markets. The company operates through three main segments: Regulated Industries, Intelligent Infrastructure, and Connected Living and Digital Commerce. The Regulated Industries segment primarily serves customers in automotive and transportation, healthcare and packaging, and renewable energy infrastructure. Within this segment, Jabil specializes in medical device contract manufacturing, providing comprehensive support, including design, engineering, and manufacturing for medical devices, surgical instruments, capital equipment, patient monitoring devices, and digital healthcare tools. Jabil’s manufacturing facilities are located in China, Ireland, Malaysia, Mexico, Singapore, and the US.

Flex Ltd. designs, engineers, manufactures, and provides supply chain solutions to original equipment manufacturers worldwide. Effective in fiscal year 2026, Flex will operate through three main segments: Integrated Technology Solutions (ITS), which focuses on communications and lifestyle products; Regulated Manufacturing Solutions (RMS), which includes industrial, automotive, and healthcare services; and Cloud and Power Infrastructure (CPI), which covers cloud, cooling, and power systems. The Regulated Manufacturing Solutions (RMS) segment provides medical device contract manufacturing services. Flex operates in over 100 locations across approximately 30 countries.

Market Ranking

The top five companies in the medical device contract manufacturing market are Jabil, Flex Ltd., Integer Holdings, Plexus, and Sanmina. Jabil operates as a vertically integrated partner, connecting device manufacturing with pharmaceutical drug delivery. This includes products like auto-injectors, pen injectors, and inhalers, with a focus on high-demand areas such as GLP-1 therapies.

Flex differentiates itself through its extensive medical network, which includes connected devices, wearable drug delivery systems, and large medical equipment, all managed within a single healthcare organization.

Integer Holdings is recognized as one of the largest medical device contract development and manufacturing organizations (CDMOs). It specializes in cardiovascular and vascular devices, neuromodulation, and cardiac rhythm management, with notable brands including Greatbatch Medical and Lake Region Medical. Integer’s capabilities extend to Class III device systems.

Plexus emphasizes its long experience with FDA Class II and Class III regulations. The company organizes its healthcare work into three main areas: medical devices and equipment, life sciences and diagnostics, and surgical systems and medical robotics, all supported by cleanroom manufacturing and aftermarket repair services.

Sanmina combines ISO 13485-certified design and manufacturing with ten FDA-registered facilities and complies with 21 CFR Part 820 and Part 11. It specializes in the automated production of disposables, imaging systems, and surgical robotics subassemblies.

In addition to these five companies, the market also includes many smaller contract manufacturers and regional specialists, contributing to a highly fragmented competitive landscape.

Related Reports:

Medical Device Contract Manufacturing Market by Device (IVD, Drug Delivery, Surgical, Orthopedic Implants), Class of Device (Class I, II, III), and Service (QMS, Process Development, Device & Component Manufacturing, Packaging) – Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]